STAT

AUGUST 31, 2024

A study meant to serve as a tie-breaker between two major trials of a heart clip made by Abbott may end up stimulating more debate among cardiologists. Results of the RESHAPE-HF 2 trial, presented at the European Society of Cardiology meeting and published in the New England Journal of Medicine on Saturday, showed that the clip improved health status and lowered hospitalizations due to heart failure, but did not reduce the number of deaths.

Hospitals 239

Hospitals 239

The Guardian - Pharmaceutical Industry

AUGUST 31, 2024

Semaglutide – contained in Ozempic and Wegovy – has ‘far-reaching benefits’, with people dying at lower rate from all causes Weight-loss drugs are poised to revolutionise healthcare by slowing down the ageing process and by allowing people to live for longer and in better health. That is the dramatic message from leading scientists after studies were presented last week at the European Society of Cardiology Conference in London.

110

110

Pharmaceutical Technology

AUGUST 31, 2024

A meta-analysis has demonstrated consistent efficacy in heart failure outcomes with SGLT2 inhibitors regardless of disease duration.

Diabetes 98

Diabetes 98

Drug Patent Watch

AUGUST 31, 2024

EPIDUO (adapalene; benzoyl peroxide) Galderma labs lp Patent: 7,964,202 Expiration: Sep 1, 2024 See More … Source

52

52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Pharmaceutical Technology

AUGUST 31, 2024

There is a strong opportunity in the heart failure (HF) space for new agents that could reduce HF-associated hospitalisations and mortality.

59

59

Pharmacy Times

AUGUST 31, 2024

Women's health extends beyond reproductive health, yet much of the research in women's health focuses on these "below the belt" health issues, despite data showing that women disproportionately suffer from certain health conditions, such as heart failure.

26

26